ARTICLE | Clinical News
Cystistat purified hyaluronic acid derivative regulatory update
September 11, 2000 7:00 AM UTC
BNC received European marketing approval for Cystistat to treat radiation cystitis and cystitis caused by infections, trauma, urolithiasis, urinary retention and neoplasia. Previously, Cystistat was m...